| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.22 | 5e-06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0003 |